Filing Details
- Accession Number:
- 0000914190-21-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-09 17:24:13
- Reporting Period:
- 2021-02-05
- Accepted Time:
- 2021-02-09 17:24:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1270905 | David Norman Eansor | 8100 Southpark Way, A-8 Littleton CO 80120 | President-Protein Sciences | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-05 | 14,114 | $106.59 | 15,432 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-05 | 18,819 | $106.59 | 34,251 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-05 | 6,000 | $378.29 | 28,251 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-05 | 4,500 | $379.62 | 23,751 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-05 | 12,833 | $380.50 | 10,918 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-05 | 2,900 | $381.52 | 8,018 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-05 | 3,700 | $382.60 | 4,318 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-05 | 1,900 | $384.15 | 2,418 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-05 | 1,100 | $385.59 | 1,318 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2021-02-05 | 14,114 | $0.00 | 14,114 | $106.59 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2021-02-05 | 18,819 | $0.00 | 18,819 | $106.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-08-18 | No | 4 | M | Direct | |
| 0 | 2023-08-18 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | $125.05 | 2024-08-09 | 11,982 | 11,982 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $125.05 | 2024-08-09 | 15,976 | 15,976 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 2,537 | 2,537 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $177.32 | 2025-08-08 | 13,550 | 13,550 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $177.32 | 2025-08-08 | 18,066 | 18,066 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 3,151 | 3,151 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $190.41 | 2026-08-07 | 15,948 | 15,948 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $190.41 | 2026-08-07 | 21,265 | 21,265 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 2,575 | 2,575 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $267.87 | 2027-08-05 | 11,488 | 11,488 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $267.87 | 2027-08-05 | 15,318 | 15,318 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $267.87 | 2027-08-05 | 24,975 | 24,975 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $267.87 | 2027-08-05 | 24,975 | 24,975 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-08-09 | 11,982 | 11,982 | Direct |
| 2024-08-09 | 15,976 | 15,976 | Direct |
| 2,537 | 2,537 | Direct | |
| 2025-08-08 | 13,550 | 13,550 | Direct |
| 2025-08-08 | 18,066 | 18,066 | Direct |
| 3,151 | 3,151 | Direct | |
| 2026-08-07 | 15,948 | 15,948 | Direct |
| 2026-08-07 | 21,265 | 21,265 | Direct |
| 2,575 | 2,575 | Direct | |
| 2027-08-05 | 11,488 | 11,488 | Direct |
| 2027-08-05 | 15,318 | 15,318 | Direct |
| 2027-08-05 | 24,975 | 24,975 | Direct |
| 2027-08-05 | 24,975 | 24,975 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $378.00 to $378.94, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.03 to $380.01, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.065 to $381.055, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.095 to $382.01, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $382.26 to $383.07, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $383.93 to $384.39, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $385.415 to $385.77, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- Fully exercisable.
- Options to purchase 3,994 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021.
- Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 4,517 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 4,516 shares vest on each of 8/8/2021 and 8/8/2022.
- Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 5,317 shares vest on 8/7/2020 and options to purchase 5,316 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.
- Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 3,830 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 3,829 shares vest on each of 8/5/2023 and 8/5/2024.
- Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021
- Options to purchase 8,325 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Billionaire Hedge Funds
